Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)
- Conditions
- Metastatic Castration-Resistant Prostate Cancer
- Registration Number
- NCT05650476
- Lead Sponsor
- Pfizer
- Brief Summary
Provide pre-approval single-patient Expanded Access (Compassionate Use) of talazoparib for patients with metastatic castration-resistant prostate cancer.
- Detailed Description
In Expanded Access, treating physicians are the Sponsors..
Expanded Access requests from treating physicians may be submitted at www.pfizercares.com; availability will depend on location/country.
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method